188 related articles for article (PubMed ID: 36656595)
1. An IBD-associated pathobiont synergises with NSAID to promote colitis which is blocked by NLRP3 inflammasome and Caspase-8 inhibitors.
Singh R; Rossini V; Stockdale SR; Saiz-Gonzalo G; Hanrahan N; D' Souza T; Clooney A; Draper LA; Hill C; Nally K; Shanahan F; Andersson-Engels S; Melgar S
Gut Microbes; 2023; 15(1):2163838. PubMed ID: 36656595
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of NLRP3 attenuates sodium dextran sulfate-induced inflammatory bowel disease through gut microbiota regulation.
Wang SL; Zhang MM; Zhou H; Su GQ; Ding Y; Xu GH; Wang X; Li CF; Huang WF; Yi LT
Biomed J; 2023 Oct; 46(5):100580. PubMed ID: 36758943
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of carboxyamidotriazole on 2,4,6-trinitrobenzene sulfonic acid-induced colitis model is associated with the inhibition of NLRP3 inflammasome and NF-κB activation.
Du X; Chen W; Wang Y; Chen C; Guo L; Ju R; Li J; Zhang D; Zhu L; Ye C
Int Immunopharmacol; 2017 Apr; 45():16-25. PubMed ID: 28152446
[TBL] [Abstract][Full Text] [Related]
4. BAFF Blockade Attenuates DSS-Induced Chronic Colitis
Zhang Y; Tao M; Chen C; Zhao X; Feng Q; Chen G; Fu Y
Front Immunol; 2022; 13():783254. PubMed ID: 35320937
[TBL] [Abstract][Full Text] [Related]
5. Escherichia coli isolates from inflammatory bowel diseases patients survive in macrophages and activate NLRP3 inflammasome.
De la Fuente M; Franchi L; Araya D; Díaz-Jiménez D; Olivares M; Álvarez-Lobos M; Golenbock D; González MJ; López-Kostner F; Quera R; Núñez G; Vidal R; Hermoso MA
Int J Med Microbiol; 2014 May; 304(3-4):384-92. PubMed ID: 24581881
[TBL] [Abstract][Full Text] [Related]
6. Probiotics alleviate inflammatory bowel disease in mice by regulating intestinal microorganisms-bile acid-NLRP3 inflammasome pathway.
Liu Z; Wang H
Acta Biochim Pol; 2021 Oct; 68(4):687-693. PubMed ID: 34648252
[TBL] [Abstract][Full Text] [Related]
7. The autoimmune susceptibility gene,
Shawki A; Ramirez R; Spalinger MR; Ruegger PM; Sayoc-Becerra A; Santos AN; Chatterjee P; Canale V; Mitchell JD; Macbeth JC; Gries CM; Tremblay ML; Hsiao A; Borneman J; McCole DF
Gut Microbes; 2020 Nov; 11(6):1547-1566. PubMed ID: 32586195
[TBL] [Abstract][Full Text] [Related]
8. Protective and aggravating effects of Nlrp3 inflammasome activation in IBD models: influence of genetic and environmental factors.
Bauer C; Duewell P; Lehr HA; Endres S; Schnurr M
Dig Dis; 2012; 30 Suppl 1():82-90. PubMed ID: 23075874
[TBL] [Abstract][Full Text] [Related]
9. Hydroxytyrosol alleviates dextran sodium sulfate-induced colitis by inhibiting NLRP3 inflammasome activation and modulating gut microbiota in vivo.
Miao F
Nutrition; 2022 May; 97():111579. PubMed ID: 35248848
[TBL] [Abstract][Full Text] [Related]
10. The Pathogenic Role of NLRP3 Inflammasome Activation in Inflammatory Bowel Diseases of Both Mice and Humans.
Liu L; Dong Y; Ye M; Jin S; Yang J; Joosse ME; Sun Y; Zhang J; Lazarev M; Brant SR; Safar B; Marohn M; Mezey E; Li X
J Crohns Colitis; 2017 Jun; 11(6):737-750. PubMed ID: 27993998
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a Causal Role for Escherichia coli Strains Identified as Adherent-Invasive (AIEC) in Intestinal Inflammation.
Kittana H; Gomes-Neto JC; Heck K; Juritsch AF; Sughroue J; Xian Y; Mantz S; Segura Muñoz RR; Cody LA; Schmaltz RJ; Anderson CL; Moxley RA; Hostetter JM; Fernando SC; Clarke J; Kachman SD; Cressler CE; Benson AK; Walter J; Ramer-Tait AE
mSphere; 2023 Apr; 8(2):e0047822. PubMed ID: 36883813
[TBL] [Abstract][Full Text] [Related]
12. Curcumin alleviates DSS-induced colitis via inhibiting NLRP3 inflammsome activation and IL-1β production.
Gong Z; Zhao S; Zhou J; Yan J; Wang L; Du X; Li H; Chen Y; Cai W; Wu J
Mol Immunol; 2018 Dec; 104():11-19. PubMed ID: 30396035
[TBL] [Abstract][Full Text] [Related]
13. Targeting NLRP3 Inflammasome in Inflammatory Bowel Disease: Putting out the Fire of Inflammation.
Shao BZ; Wang SL; Pan P; Yao J; Wu K; Li ZS; Bai Y; Linghu EQ
Inflammation; 2019 Aug; 42(4):1147-1159. PubMed ID: 30937839
[TBL] [Abstract][Full Text] [Related]
14. Walnut oil alleviates DSS-induced colitis in mice by inhibiting NLRP3 inflammasome activation and regulating gut microbiota.
Miao F; Shan C; Ma T; Geng S; Ning D
Microb Pathog; 2021 May; 154():104866. PubMed ID: 33775855
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-200c-5p targets NIMA Related Kinase 7 (NEK7) to inhibit NOD-like receptor 3 (NLRP3) inflammasome activation, MODE-K cell pyroptosis, and inflammatory bowel disease in mice.
Wu G; Zhang D; Yang L; Wu Q; Yuan L
Mol Immunol; 2022 Jun; 146():57-68. PubMed ID: 35447415
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of NLRP3 inflammasome activation and its role in NSAID-induced enteropathy.
Higashimori A; Watanabe T; Nadatani Y; Takeda S; Otani K; Tanigawa T; Yamagami H; Shiba M; Tominaga K; Fujiwara Y; Arakawa T
Mucosal Immunol; 2016 May; 9(3):659-68. PubMed ID: 26349656
[TBL] [Abstract][Full Text] [Related]
17. Jmjd3 regulates inflammasome activation and aggravates DSS-induced colitis in mice.
Huang M; Wang Q; Long F; Di Y; Wang J; Zhun Zhu Y; Liu X
FASEB J; 2020 Mar; 34(3):4107-4119. PubMed ID: 31971317
[TBL] [Abstract][Full Text] [Related]
18. 3-(2-Oxo-2-phenylethylidene)-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-one (compound 1), a novel potent Nrf2/ARE inducer, protects against DSS-induced colitis via inhibiting NLRP3 inflammasome.
Wang Y; Wang H; Qian C; Tang J; Zhou W; Liu X; You Q; Hu R
Biochem Pharmacol; 2016 Feb; 101():71-86. PubMed ID: 26588861
[TBL] [Abstract][Full Text] [Related]
19. NLRP3 Inflammasome and Inflammatory Bowel Disease.
Zhen Y; Zhang H
Front Immunol; 2019; 10():276. PubMed ID: 30873162
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic implications of inflammasome in inflammatory bowel disease.
Khatri V; Kalyanasundaram R
FASEB J; 2021 May; 35(5):e21439. PubMed ID: 33774860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
